Treatment for Cellulitis and UTI
For a patient with cellulitis under the arm and a urinary tract infection (UTI), treat with clindamycin for cellulitis and trimethoprim-sulfamethoxazole for the UTI.
Cellulitis Treatment
First-line therapy:
- For nonpurulent cellulitis (no abscess or purulent drainage), use antibiotics active against streptococci, which are the most common causative pathogens 1, 2
- Recommended oral options include:
- Penicillin, amoxicillin, amoxicillin-clavulanate, dicloxacillin, cephalexin, or clindamycin 1
- Duration of therapy should be 5 days if clinical improvement occurs within this timeframe 1, 3
MRSA considerations:
- MRSA is an unusual cause of typical cellulitis without purulent drainage 1
- Consider MRSA coverage if there is:
- Penetrating trauma
- Purulent drainage
- Concurrent evidence of MRSA infection elsewhere
- No response to beta-lactam therapy 1
- If MRSA coverage is needed, options include:
Additional management:
- Elevation of the affected area to promote gravity drainage of edema 1
- Treat any predisposing conditions such as edema or underlying cutaneous disorders 1
- For axillary cellulitis, carefully examine for any fissuring or maceration that may serve as entry points for bacteria 1
UTI Treatment
First-line therapy for uncomplicated UTI:
- Trimethoprim-sulfamethoxazole (TMP-SMX): 4 teaspoonfuls (20 mL) every 12 hours for 10-14 days 4
- Alternative options include nitrofurantoin, fosfomycin, or pivmecillinam 5, 6
Duration of therapy:
Special considerations:
- Local antibiotic resistance patterns should guide empiric therapy 5, 6
- If the patient has risk factors for resistant organisms, consider broader coverage 5, 6
- For patients with complicated UTI and bacteremia, 10 days of therapy is appropriate 7
Combined Treatment Approach
Optimal regimen for dual infection:
- Clindamycin for cellulitis: Effective against both streptococci and MRSA if present 1
- TMP-SMX for UTI: FDA-approved for UTIs caused by susceptible strains of common uropathogens 4
- This combination provides appropriate coverage for both infections without unnecessary antibiotic overlap 1, 4
Duration:
- Cellulitis: 5 days if clinical improvement occurs 1, 3
- UTI: 10-14 days as recommended for urinary tract infections 4
Monitoring:
- Assess clinical response within 48-72 hours
- Extend treatment duration if infection has not improved within 5 days 1
- Consider hospitalization if there are signs of systemic illness, altered mental status, or hemodynamic instability 1